CoChat

Spatial immune scoring system predicts hepatocellular carcinoma recurrence

Open access

Published version of a preprint

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Abstract

Given the high recurrence rates of hepatocellular carcinoma (HCC) post-resection 1-3, improved early identification of patients at high risk for post-resection recurrence would help to improve patient outcomes and prioritize healthcare resources 4-6. Here we observed a spatial and HCC recurrence-associated distribution of natural killer (NK) cells in the invasive front and tumour centre from 61 patients. Using extreme gradient boosting and inverse-variance weighting, we developed the tumour immune microenvironment spatial (TIMES) score based on the spatial expression patterns of five biomarkers (SPON2, ZFP36L2, ZFP36, VIM and HLA-DRB1) to predict HCC recurrence risk. The TIMES score (hazard ratio = 88.2, P < 0.001) outperformed current standard tools for patient risk stratification including the TNM and BCLC systems. We validated the model in 231 patients from five multicentred cohorts, achieving a real-world accuracy of 82.2% and specificity of 85.7%. The predictive power of these biomarkers emerged through the integration of their spatial distributions, rather than individual marker expression levels alone. In vivo models, including NK cell-specific Spon2-knockout mice, revealed that SPON2 enhances IFNγ secretion and NK cell infiltration at the invasive front. Our study introduces TIMES, a publicly accessible tool for predicting HCC recurrence risk, offering insights into its potential to inform treatment decisions for early-stage HCC.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41586-025-08668-x

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 78 references

Metadata

Authors
Jia, G., He, P., Dai, T., Goh, D., Wang, J., Sun, M., Wee, F., Li, F., Lim, J. C. T., Hao, S., Liu, Y., Lim, T. K. H., Ngo, N.-T., Tao, Q., Wang, W., Umar, A., Nashan, B., Zhang, Y., Ding, C., Yeong, J., Liu, L., & Sun, C.
Affiliations
  • University of Science and Technology of China (CN)
  • Agency for Science, Technology and Research (SG)
  • Agricultural Genomics Institute at Shenzhen (CN)
  • Duke-NUS Medical School (SG)
  • Central South University (CN)
  • Fudan University (CN)
Corresponding author
  • Yeong, Joe
  • Liu, Lianxin
  • Sun, Cheng
Venue
Nature
Published
2025-03-12
Volume
640
Issue
8060
Pages
1031-1041
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4408348028
Cited by
104
References
78
Citations by year
2026: 63 · 2025: 41
FWCI
57.36
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature (publishedVersion)
  • Research Square (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
Keywords
hepatocellular carcinoma, tumor recurrence prediction, tumor immune microenvironment, natural killer cells, SPON2, ZFP36L2, ZFP36, VIM, HLA-DRB1, extreme gradient boosting, inverse variance weighting, risk stratification, NK cell infiltration, hepatectomy
MeSH terms
Animals, Female, Carcinoma, Hepatocellular, Humans, Interferon-gamma, Killer Cells, Natural, Liver Neoplasms, Male, Middle Aged, Neoplasm Recurrence, Local, Biomarkers, Tumor, Reproducibility of Results, Cohort Studies, Extracellular Matrix Proteins, Mice, Knockout, Mice, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spatial immune scoring system predicts hepatocellular carcinoma recurrence. https://app.cochat.ai/papers/10.1038/s41586-025-08668-x
The paper
Jia, G., He, P., Dai, T., Goh, D., Wang, J., Sun, M., Wee, F., Li, F., Lim, J. C. T., Hao, S., Liu, Y., Lim, T. K. H., Ngo, N.-T., Tao, Q., Wang, W., Umar, A., Nashan, B., Zhang, Y., Ding, C., . . . Sun, C. (2025). Spatial immune scoring system predicts hepatocellular carcinoma recurrence. Nature. https://doi.org/10.1038/s41586-025-08668-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.